• KOL
    • Human Herpesvirus
    • Human Herpesvirus 6 In...
    • Human Herpesvirus 6 in Bronchalveolar Lavage Fluid after Lung Transplantation: A Risk Factor for Bronchiolitis Obliterans Syndrome?: Influence Statistics

      Expert Impact

      Concepts for whichthey havehas direct influence:Human herpesvirus,Lung transplantation,Bronchiolitis obliterans,Acute rejection,Herpesvirus 6,Lavage fluid,Bos bronchiolitis obliterans,Acute rejection bos.

      Key People For Human Herpesvirus

      Top KOLs in the world
      #1
      Koichi Yamanishi
      human herpesvirus herpes zoster monoclonal antibodies
      #2
      Dharam V Ablashi
      human herpesvirus viral antigens aids patients
      #3
      Robert Charles Gallo
      human herpesvirus cell leukemia reverse transcriptase
      #4
      Philip E Pellett
      human herpesvirus simplex virus united states
      #5
      Yoshizo Asano
      human herpesvirus exanthem subitum varicella vaccine
      #6
      Lawrence Corey
      simplex virus genital herpes south africa

      Human Herpesvirus 6 in Bronchalveolar Lavage Fluid after Lung Transplantation: A Risk Factor for Bronchiolitis Obliterans Syndrome?

      Abstract

      Bronchiolitis obliterans syndrome (BOS) is the limiting factor to long-term survival after lung transplantation. Previous studies suggested respiratory viral tract infections are associated with the development of BOS. To identify the impact of virus detection in bronchoalveolar lavage (BAL) fluid, we analyzed BAL samples from 87 consecutive lung transplant recipients for human herpesvirus (HHV)-6, Epstein-Barr virus, Herpes simplex virus 1/2, Cytomegalovirus, respiratory syncytical virus and adenovirus by PCR. Acute rejection, BOS and death were recorded for a mean follow-up time of 3.27 +/- 0.47 years. Results of PCR analysis and other potential risk factors were entered into a Cox regression analysis of BOS predictors and death. Only acute rejection was a distinct risk factor for BOS of all stages, death and death from BOS. HHV-6 was detected in 20 patients. Univariate and multivariate analysis revealed that HHV-6 was associated with an increased risk to develop BOS > orb = stage 1 and death, separate from the risk attributable to acute rejection. Identification of HHV-6 DNA in BAL fluid is a potential risk factor for BOS. Our results warrant further studies to elucidate a possible causal link between HHV-6 and BOS.

      Sign-in to see all concepts, it's free!

       

    Download on the App StoreGet it on Google Play

    Copyright © 2023 Key Opinion Leaders, LLC.